Nuvectis Pharma Stock Filter Stocks by Fundamentals
NVCT Stock | USD 5.04 0.24 4.55% |
Nuvectis Pharma fundamentals help investors to digest information that contributes to Nuvectis Pharma's financial success or failures. It also enables traders to predict the movement of Nuvectis Stock. The fundamental analysis module provides a way to measure Nuvectis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nuvectis Pharma stock.
Nuvectis |
Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
All Next | Launch Module |
Nuvectis Fundamentals
Return On Equity | -1.4 | ||||
Return On Asset | -0.61 | ||||
Current Valuation | 80.21 M | ||||
Shares Outstanding | 19.32 M | ||||
Shares Owned By Insiders | 51.52 % | ||||
Shares Owned By Institutions | 6.97 % | ||||
Number Of Shares Shorted | 1.39 M | ||||
Price To Book | 8.86 X | ||||
EBITDA | (22.9 M) | ||||
Net Income | (22.26 M) | ||||
Cash And Equivalents | 13.57 M | ||||
Cash Per Share | 0.93 X | ||||
Total Debt | 6.98 M | ||||
Current Ratio | 5.20 X | ||||
Book Value Per Share | 0.58 X | ||||
Cash Flow From Operations | (15.95 M) | ||||
Short Ratio | 4.74 X | ||||
Earnings Per Share | (1.16) X | ||||
Target Price | 22.0 | ||||
Number Of Employees | 13 | ||||
Beta | 0.4 | ||||
Market Capitalization | 102.01 M | ||||
Total Asset | 19.18 M | ||||
Retained Earnings | (54.24 M) | ||||
Working Capital | 12.2 M | ||||
Net Asset | 19.18 M |
About Nuvectis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nuvectis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nuvectis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nuvectis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.